Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
This study has been withdrawn prior to enrollment.
( due to lack of finance )
Study NCT00506701   Information provided by Herlev Hospital

First Received on July 23, 2007.   Last Updated on February 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Obstructive Lung Disease
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
More general conditions related to this trial
Cardiovascular Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Tadalafil
Additional drug interventions recognized in this trial
Phosphodiesterase 5 Inhibitors
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Herlev Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services